Skip to main content

Rytary News

Subcutaneous Infusion of Levodopa-Carbidopa Beneficial for Parkinson Disease

THURSDAY, April 11, 2024 – Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease

Rytary patient information at Drugs.com